Press release
SMi Group announce 6th annual RNAi, miRNA and siRNA conference, 27th & 28th June 2011
Learn how top pharma companies are utilising RNAi potential at SMi’s RNAi, miRNA and siRNA
Join the top 50 Pharma companies as they discuss some of the most prominent issues that stand in the way of the successful harnessing of the vast potential that this process possess
RNAi holds vast potential for the pharmaceutical and biotechnology industry. However now is a crucial time in the development of this exiting area of research, where knowledge and contacts are key to preserving, and building upon, your existing programmes in nucleic acid delivery and inference. It is vital that remaining budgets are utilised in effective ways, new technology and breakthroughs are investigated, and investments are protected by informed decision making.
Key topics include:
• The latest successes in miRNA, siRNA and oligonucleotide therapeutic development
• Tackling delivery issues
• Clinical trial considerations
• Regulatory issues
• Bioinformatics and computational support.
• Epigenetics
• KOL Panel Discussion: The effect of pharma cuts on the further development and commercialisation of RNAi technologies
For more information on the conference and workshop visit http://www.smi-online.co.uk/2011rnai36.asp contact Patrick Bedwei on +44 (0) 20 7827 6151 or email at pbedwei@smi-online.co.uk
About SMi Group
RNAi, miRNA and siRNA is just one of the many conferences that are a part of the SMi Group portfolio.
The SMi Group is a world leader in business to business information. With nearly two decades in the business, thousands of senior executives from blue chip companies have already benefitted from SMi’s highly targeted conferences, workshops and publications. For more information visit www.smi-online.co.uk
For further information, contact:
Patrick Bedwei
Tel: +44 (0) 20 7827 6151
Email: pbedwei@smi-online.co.uk
SMi Group Ltd
Unit 124
30 Great Guildford Street
London
SE1 0HS
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release SMi Group announce 6th annual RNAi, miRNA and siRNA conference, 27th & 28th June 2011 here
News-ID: 173818 • Views: …
More Releases from SMi Group
Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Con …
SMi Reports: Exclusive speaker interview with Todd Krueger at AOBiome released for the Pain Therapeutics Conference
The pain therapeutics industry has grown at an exponential rate in recent years. The 22nd Annual Pain Therapeutics conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation.
Industry leaders will uncover the…
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual High …
Now in its 6th year, the Highly Potent Active Pharmaceutical Ingredients conference offers you peer-to-peer networking with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more. Taking place on 9th and 10th May in London, UK.
With a key focus on expanding your community and exploring the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading…
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast C …
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks' time on April 27th and 28th, 2022.
With just three weeks remaining until the highly anticipated conference, SMi Group are delighted to announce a key FDA Speaker joining the 5th Annual Pharmaceutical Microbiology East Coast Conference. This event will take place on April 27th and…
Group Captain (ret'd) Robert Daisley invites you to attend Air Mission Planning …
SMi Group reports: Chairman Group Captain (ret'd) Robert Daisley of the Air Mission Planning and Support Conference cordially invites experts to join the conference in London, UK in one week.
With only one week remaining, SMi Group is delighted to publish an invitation letter for SMi's 13th Annual Air Mission Planning & Support Conference, taking place on the 6th and 7th April 2022 in London, UK from the conference chairman.
The…
More Releases for RNAi
RNAi Technology Market to see Booming Business Sentiments
The latest study released on the Global RNAi Technology Market by USD Analytics Research evaluates market size, trend, and forecast to 2030. The RNAi Technology market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors.
Key Players…
RNAi Technology Market to see Booming Business Sentiments
The "Global RNAi Technology" intelligence report, just published by USD Analytics, covers insurers' micro-level study of important market niches, product offers, and sales channels. In order to determine market size, potential, growth trends, and competitive environment, the Global RNAi Technology provides dynamic views. Both primary and secondary sources of data were used to generate the research, which has both qualitative and quantitative depth. Several of the major figures the study…
Global RNAi Drug Pipeline Analysis
“Global RNAi Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drugs being developed based upon RNAi technology. Research report covers all the ongoing drugs being developed in various development phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Country of Development and detailed analysis on the development process. Insight for each drug profile in…
Global RNA Interference (RNAi) Therapy Market Outlook 2018
The popularity of RNAi technology has been increasing in recent times as is has become a major component of basic research, and in drug discovery. Over the years this technology has become an integral part of the process of determining the functions of gene, in analyzing pathways, and in the validation of the target both in academia and in industry.
Since discovery, RNA interference is considered to be a turning…
Global RNAI Interfering System Market Research Report 2017
Summary
RNAI Interfering System Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China).
The report firstly introduced the RNAI Interfering System basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes;…
Global RNAI Vector Market Research Report 2017
Summary
RNAI Vector Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China).
The report firstly introduced the RNAI Vector basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures,…
